Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue SUPPL. 1, 2010, Pages

  Hirata, Kenro ^a   Suzuki, Hidekazu ^a   Nishizawa, Toshihiro ^b   Tsugawa, Hitoshi ^a   Muraoka, Hiroe ^c   Saito, Yoshimasa ^a   Matsuzaki, Juntaro ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Clarithromycin; Efflux pump; Helicobacter pylori; Phe Arg naphthylamide

Indexed keywords

CARRIER PROTEIN; CLARITHROMYCIN; MESSENGER RNA; RNA 23S; BACTERIAL PROTEIN; BACTERIAL RNA; DIPEPTIDE; PHENYLALANINE ARGININE BETA-NAPHTHYLAMIDE; RIBOSOME DNA;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GENE CLUSTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; AGED; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELICOBACTER INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PROTEIN CONFORMATION; RNA GENE;

AGED; BACTERIAL PROTEINS; CLARITHROMYCIN; DIPEPTIDES; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, RRNA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MODELS, MOLECULAR; POINT MUTATION; PROTEIN CONFORMATION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S;

EID: 77951551029     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06220.x     Document Type: Conference Paper

References (23)

1. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J. Gastroenterol. 2007 42 : 1 15. (Pubitemid 46357245)
2. Masuda H, Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. Pathobiology 2004 71 : 159 163. (Pubitemid 38437711)
3. Versalovic J, Osato MS, Spakovsky K et al. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 1997 40 : 283 286. (Pubitemid 27394025)
4. Masaoka T, Suzuki H, Kurabayashi K, Kamiya AG, Ishii H. Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Aliment. Pharm. Ther. 2004 20 (Suppl. 1 68 73. (Pubitemid 39120274)
5. Paulsen IT. Multidrug efflux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 2003 6 : 446 451. (Pubitemid 37345408)
6. Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 2004 10 : 12 26. (Pubitemid 38128588)
7. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 1995 16 : 45 55.
8. Li XZ, Nikaido H, Poole K. Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1995 39 : 1948 1953.
9. Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 2007 51 : 3212 3216. (Pubitemid 350067530)
10. Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ, Hancock RE. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob. Agents Chemother. 2000 44 : 248 254. (Pubitemid 30060714)
11. van Amsterdam K, Bart A, van der Ende A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob. Agents Chemother. 2005 49 : 1477 1482. (Pubitemid 40463379)
12. Pages JM, Masi M, Barbe J. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 2005 11 : 382 389. (Pubitemid 41080580)
13. Lomovskaya O, Warren MS, Lee A et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 2001 45 : 105 116. (Pubitemid 32039101)
14. Cetinkaya E, Coban AY, Durupinar B. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Mikrobiyol. Bul. 2008 42 : 553 561.
15. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids. Res. 2003 31 : 3381 3385. (Pubitemid 37442164)
16. Stone GG, Shortridge D, Flamm RK et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996 1 : 227 228. (Pubitemid 126671165)
17. 21acteria That Grow Aerobically: Approved Standard 6th Edition, M7-A6.
18. Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 2000 405 : 914 919. (Pubitemid 30435040)
19. Akama H, Matsuura T, Kashiwagi S et al. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 2004 279 : 25939 25942. (Pubitemid 38798733)
20. Higgins MK, Bokma E, Koronakis E, Hughes C, Koronakis V. Structure of the periplasmic component of a bacterial drug efflux pump. Proc. Natl Acad. Sci. USA 2004 101 : 9994 9999. (Pubitemid 38891184)
21. Kutschke A, de Jonge BL. Compound efflux in Helicobacter pylori. Antimicrob. Agents Chemother. 2005 49 : 3009 3010. (Pubitemid 40917628)
22. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007 56 : 1353 1357. (Pubitemid 47517826)
23. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann. Intern. Med. 2008 148 : 923 931.